Medicare Enrolled

Dr. David Gill, D.O.

Neurology · Saginaw, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
800 COOPER AVE, Saginaw, MI 48602
9895837090
Registered in NPPES since 2010
NPI: 1447562236 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gill from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gill? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gill

Dr. David Gill is a neurology specialist in Saginaw, MI, with 16 years of NPI registration. Based on federal Medicare data, Dr. Gill performed 720 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Gill received a total of $4,666 from 48 pharmaceutical and/or device companies across 301 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gill is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years of NPI registration ▲ Top 23% volume in MI $4,666 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
720
Medicare services
Top 23% in MI for neurology
Not available
Unique patients (not deduplicated)
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
181 $80 $220
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
143 $62 $105
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
107 $97 $198
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
95 $34 $79
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
58 $43 $107
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
45 $112 $319
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
38 $54 $152
Nerve conduction studies, 5-6 tests
A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction.
24 $55 $214
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
16 $134 $286
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
13 $101 $341
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,666
Total received (2018-2024)
Avg $667/year across 7 years
Top 33% in MI for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
301
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,182
2023
$1,155
2022
$605
2021
$883
2020
$339
2019
$202
2018
$299

Payments by company (2024)

ABBVIE INC.
$354
PFIZER INC.
$118
Celgene Corporation
$87
Otsuka America Pharmaceutical, Inc.
$85
Lilly USA, LLC
$62
Biogen, Inc.
$59
Novartis Pharmaceuticals Corporation
$38
UCB, Inc.
$37
Neurocrine Biosciences, Inc.
$36
EMD Serono, Inc.
$26
Kyowa Kirin, Inc.
$26
Lundbeck LLC
$25
Grifols USA, LLC
$24
Alexion Pharmaceuticals, Inc.
$24
MITSUBISHI TANABE PHARMA AMERICA, INC.
$23
Otsuka Pharmaceutical Development & Commercialization, Inc.
$21
Eisai Inc.
$20
Neurelis, Inc.
$19
HOSPIRA, INC.
$18
Genentech USA, Inc.
$18
CATALYST PHARMACEUTICALS, INC.
$17
ARGENX US, INC.
$16
Teva Pharmaceuticals USA, Inc.
$15
Acorda Therapeutics, Inc
$14
Top 3 companies account for 47.4% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$932
Biogen, Inc.
$549
UCB, Inc.
$193
Lilly USA, LLC
$177
Celgene Corporation
$174
Novartis Pharmaceuticals Corporation
$172
Acorda Therapeutics, Inc
$168
PFIZER INC.
$156
Neurocrine Biosciences, Inc.
$155
Lundbeck LLC
$151
EMD Serono, Inc.
$148
Biohaven Pharmaceuticals, Inc.
$130
Teva Pharmaceuticals USA, Inc.
$118
Amgen Inc.
$108
Otsuka America Pharmaceutical, Inc.
$104
Alexion Pharmaceuticals, Inc.
$101
Janssen Pharmaceuticals, Inc
$84
Sunovion Pharmaceuticals Inc.
$75
Allergan, Inc.
$67
Neurelis, Inc.
$64
SK Life Science, Inc.
$55
Eisai Inc.
$55
Kyowa Kirin, Inc.
$54
Genentech USA, Inc.
$53
GENZYME CORPORATION
$53
Avanir Pharmaceuticals, Inc.
$42
AbbVie Inc.
$38
E.R. Squibb & Sons, L.L.C.
$37
ARGENX US, INC.
$37
JAZZ PHARMACEUTICALS INC.
$32
Biohaven Pharmaceutical Holding Company Ltd.
$31
Amneal Pharmaceuticals LLC
$30
UPSHER-SMITH LABORATORIES LLC
$30
Almatica Pharma LLC
$27
Boston Scientific Corporation
$24
Grifols USA, LLC
$24
MITSUBISHI TANABE PHARMA AMERICA, INC.
$23
Adamas Pharmaceuticals, Inc.
$23
ACADIA Pharmaceuticals Inc
$21
Otsuka Pharmaceutical Development & Commercialization, Inc.
$21
Upsher-Smith Laboratories LLC
$19
HOSPIRA, INC.
$18
LivaNova USA, Inc.
$17
Corium, LLC
$17
CATALYST PHARMACEUTICALS, INC.
$17
Cala Health, Inc.
$16
Supernus Pharmaceuticals, Inc.
$15
Horizon Therapeutics plc
$11
Top 3 companies account for 35.9% of all-time payments
Associated products mentioned in payments ›
ADLARITY · ADUHELM · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BOTOX · Briviact · CALA TRIO · DUOPA · EMGALITY · EPIDIOLEX · Enspryng · FYCOMPA · Fycompa · GOCOVRI · Gamunex-C · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · Leqembi · MAYZENT · Mavenclad · NAPRELAN · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · Ocrevus Zunovo · PANZYGA · PAXLOVID · QULIPTA · RADICAVA · RAYOS · REXULTI · RYTARY · Rebif · Soliris · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TYSABRI · UBRELVY · ULTOMIRIS · VALTOCO · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Varithena Administration Pack · XARELTO · ZEPOSIA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in Saginaw?
Compare neurologists in the Saginaw area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
17
County median income
$58,347
Nearest hospital to ZIP centroid (approximate)
COVENANT MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gill is a clinical cardiology specialist, with above-average Medicare volume (top 23% in MI), with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gill experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gill performed 181 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Gill receive payments from pharmaceutical companies?
Yes. Dr. Gill received a total of $4,666 from 48 companies across 301 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gill's costs compare to other neurologists in Saginaw?
Dr. Gill's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gill) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →